217 related articles for article (PubMed ID: 18174950)
1. Effects of endocrine disruptors on dehydroepiandrosterone sulfotransferase and enzymes involved in PAPS synthesis: genomic and nongenomic pathways.
Harris R; Turan N; Kirk C; Ramsden D; Waring R
Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):51-4. PubMed ID: 18174950
[TBL] [Abstract][Full Text] [Related]
2. The effect of plasticisers on "sulphate supply" enzymes.
Turan N; Waring RH; Ramsden DB
Mol Cell Endocrinol; 2005 Dec; 244(1-2):15-9. PubMed ID: 16223563
[TBL] [Abstract][Full Text] [Related]
3. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
[TBL] [Abstract][Full Text] [Related]
4. Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation.
Klaassen CD; Boles JW
FASEB J; 1997 May; 11(6):404-18. PubMed ID: 9194521
[TBL] [Abstract][Full Text] [Related]
5. Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification.
Harris RM; Waring RH
Curr Drug Metab; 2008 May; 9(4):269-75. PubMed ID: 18473744
[TBL] [Abstract][Full Text] [Related]
6. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
[TBL] [Abstract][Full Text] [Related]
7. Function and organization of the human cytosolic sulfotransferase (SULT) family.
Coughtrie MWH
Chem Biol Interact; 2016 Nov; 259(Pt A):2-7. PubMed ID: 27174136
[TBL] [Abstract][Full Text] [Related]
8. Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.
Tyapochkin E; Cook PF; Chen G
Biochemistry; 2008 Nov; 47(45):11894-9. PubMed ID: 18928301
[TBL] [Abstract][Full Text] [Related]
9. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.
Xu Z; Wood TC; Adjei AA; Weinshilboum RM
Drug Metab Dispos; 2001 Feb; 29(2):172-8. PubMed ID: 11159808
[TBL] [Abstract][Full Text] [Related]
10. Inactivating PAPSS2 mutations in a patient with premature pubarche.
Noordam C; Dhir V; McNelis JC; Schlereth F; Hanley NA; Krone N; Smeitink JA; Smeets R; Sweep FC; Claahsen-van der Grinten HL; Arlt W
N Engl J Med; 2009 May; 360(22):2310-8. PubMed ID: 19474428
[TBL] [Abstract][Full Text] [Related]
11. Human liver cytosolic sulfotransferase 2A1-dependent dehydroepiandrosterone sulfation assay by ultra-high performance liquid chromatography-tandem mass spectrometry.
Bansal S; Lau AJ
J Pharm Biomed Anal; 2016 Feb; 120():261-9. PubMed ID: 26760244
[TBL] [Abstract][Full Text] [Related]
12. The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells.
Takeshita A; Inagaki K; Igarashi-Migitaka J; Ozawa Y; Koibuchi N
J Endocrinol; 2006 Sep; 190(3):897-902. PubMed ID: 17003290
[TBL] [Abstract][Full Text] [Related]
13. Enzyme kinetics of conjugating enzymes: PAPS sulfotransferase.
James MO
Methods Mol Biol; 2014; 1113():187-201. PubMed ID: 24523114
[TBL] [Abstract][Full Text] [Related]
14. 3'-Phosphoadenosine-5'-phosphosulfate: photoaffinity ligand for sulfotransferase enzymes.
Otterness DM; Powers SP; Miller LJ; Weinshilboum RM
Mol Pharmacol; 1991 Jan; 39(1):34-41. PubMed ID: 1987450
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of endocrine disruption: cluster analysis of effects of plasticisers on Phase 1 and Phase 2 metabolism of steroids.
Waring RH; Ramsden DB; Jarratt PD; Harris RM
Int J Androl; 2012 Jun; 35(3):415-23. PubMed ID: 22372686
[TBL] [Abstract][Full Text] [Related]
16. Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: studies on the formation of catalytically non-productive enzyme complexes.
Gulcan HO; Duffel MW
Arch Biochem Biophys; 2011 Mar; 507(2):232-40. PubMed ID: 21187059
[TBL] [Abstract][Full Text] [Related]
17. Comparative toxicity, oxidative stress and endocrine disruption potential of plasticizers in JEG-3 human placental cells.
Pérez-Albaladejo E; Fernandes D; Lacorte S; Porte C
Toxicol In Vitro; 2017 Feb; 38():41-48. PubMed ID: 27825933
[TBL] [Abstract][Full Text] [Related]
18. Sulfation pathways in plants.
Koprivova A; Kopriva S
Chem Biol Interact; 2016 Nov; 259(Pt A):23-30. PubMed ID: 27206694
[TBL] [Abstract][Full Text] [Related]
19. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions.
Ghisari M; Bonefeld-Jorgensen EC
Toxicol Lett; 2009 Aug; 189(1):67-77. PubMed ID: 19463926
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disruption: In silico interactions between phthalate plasticizers and corticosteroid binding globulin.
Sheikh IA; Beg MA
J Appl Toxicol; 2017 Dec; 37(12):1471-1480. PubMed ID: 28677244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
